What Savara Investors Should Know About 580K Options
Savara investors should stay focused on how insider moves and regulatory timelines interact with a growing biotech st...
Learn when bonds may outperform stocks for retirement, with practical timing cues and risk considerations.
24,889 articlesSavara investors should stay focused on how insider moves and regulatory timelines interact with a growing biotech st...
As chatter swirls about SpaceX joining the NASDAQ-100, savvy investors are asking for a safer, higher-conviction pick...
Cerebras stock is climbing as fresh news and growing AI demand spark investor excitement. This guide breaks down the ...
In a year of sharp rotation, the Vanguard FTSE DEVELOPED Markets ETF ex US is outperforming the S&P 500—yet the decad...
Red Cat stock faced a sharp move that sparked questions about its future. This article breaks down what can cause a s...
A senior executive recently reduced his stake in CATY by one third through an open market sale. This article explains...
A biotech stock that surged 135% in a year suddenly sees a big investor trim its stake by about $44 million. Here’s h...
In 2026 market conditions, the Vanguard High Dividend Yield ETF posted stronger five-year gains than SCHD, while deca...
Oklo stock fell further as traders digested quarterly results and a new regulatory filing. This article breaks down w...
Investors are shifting away from speculative hydrogen plays toward a blue-chip, high-yield industrial stock. Here’s w...
A rival’s blowout earnings stirred optimism across hardware names. This piece breaks down why super micro computer st...
A sharp rally in the First Trust NASDAQ Cybersecurity ETF (CIBR) outperformed the S&P 500 in early June 2026, sparkin...